Scientific Forum

6th Korean Forum on Pharmaceutical Formulation Technology

June 23, 2026​ | Suwon, South Korea


Overview

This free one-day forum is an excellent opportunity for lab managers and scientists working in formulation development, process optimization, scale-up and production to learn about formulation technologies using EUDRAGIT® polymers and their various applications, including immediate, enteric and sustained release in oral drug delivery.

Over the courses, the oral drug delivery experts will guide you through all relevant aspects from polymer functionalities to advanced formulation designs. The agenda will allow for expert discussions and exchange of know-how. Attendees will be able to apply their learnings from this forum in their daily work.

Whether you are a newcomer to the world of coatings for solid oral dosage forms, or a seasoned formulation expert looking to refresh your knowledge of formulation technologies especially with EUDRAGIT®, we look forward to welcoming you to this forum.


Key learnings for participants

  • The EUDRAGIT® world - Products and nomenclature
  • Ready-to-use taste masking, and moisture protection with EUDRAGIT® polymers
  • Formulation principles for enteric formulations using EUDRAGIT® polymers
  • Recent advances in solubility enhancement
  • EUDRACAP® ready to fill enteric capsules for early drug development up to drug product manufacturing of highly sensitive molecules
  • EUDRATEC® Advanced oral drug delivery technology platform for modified release using EUDRAGIT® polymers





Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.



Details
Participation fee: Free of charge 
Workshop language: English / Korean



Agenda
The program will start at 9:00 a.m. on Tuesday, Jun 23rd, 2026 and finish at 4:30 p.m. To see the detailed items please click here.



Venue
The workshop will take place at:
Suwon Convention Center, Room. 406-408
Suwon-si, Kyunggi-do
South Korea

Fill out the form to register for the workshop:

Agenda

08:00 | Registration

09:00 | Welcome speech
Prof. Cheong-Weon Cho, Chungnam National University (President of KSPST)

09:15 | Introduction of Evonik
Thomas Choi, Cluster Head of Evonik Korea

09:30 | Introduction of Ace Biopharm
Byunggyu Min, CEO of Ace Biopharm

MORNING SESSION Prof. Simmyung Yook (School of Pharmacy), Sungkyunkwan University

09:45 | The EUDRAGIT® world - Products and nomenclature
Rachel Roh, Business Manager of Health Care, Evonik Korea
Evonik Korea

10:30 | Ready-to-use high gloss cosmetic coatings, taste masking, and moisture protection with EUDRAGIT® polymers
Shota Ukeba, Technical Service Staff of OpenPharma Lab
Evonik Japan

11:30 | Coffee break

11:45 | Formulation principles for enteric formulations using EUDRAGIT® polymers
Henry Han, Head of Formulation and Application Service Health Care
Evonik Great China Region

12:30 | Lunch & Networking

AFTERNOON SESSION Prof. Min-Jun Baek (Department of Bio and Brain Engineering), KAIST

14:00 | Recent advances in solubility enhancement
Tatsuya Ishii, Manager of OpenPharma Lab
Evonik Japan Co., Ltd.

14:45 | EUDRACAP® ready to fill enteric capsules for early drug development up to drug product manufacturing of highly sensitive molecules
Dr. Seyedreza Goldoozian, Head of Application Technology EMEA
Evonik Operations GmbH

15:10 | EUDRATEC® Advanced oral drug delivery technology platform for modified release using EUDRAGIT® polymers
Dr. Seyedreza Goldoozian, Head of Application Technology EMEA
Evonik Operations GmbH

15:35 | Trouble shooting & Q&A session

16:00 | Wrap-up

16:15 | End of the seminar and time for individual discussions





Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.




QUESTIONS? 

Geum bee (Rachel) Roh
Business Manager

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register